CD274 and neoplasm: Beyond the TPS and CPS scoring system, the PD-L1 tumor-infiltrating immune cell (IC) status was defined by the percentage of PD-L1-positive immune cells in the tumor microenvironment, which was seldom used in clinical trials (18).